Evidence for the participation of the neuron-specific CDK5 activator p35 during laminin-enhanced axonal growth

被引:0
|
作者
Paglini, G
Pigino, G
Kunda, P
Morfini, G
Maccioni, R
Quiroga, S
Ferreira, A
Cáceres, A
机构
[1] CONICET, Inst Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina
[2] Univ Chile, Lab Biol Celular & Mol, Santiago 5000, Chile
[3] Univ Nacl Cordoba, CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina
[4] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA
[5] Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA
关键词
cdk5; p35; neurons; development; axon; growth; cones; MAP1b; phosphorylation; antisense oligonucleotides; neuronal cultures;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cultures of cerebellar macroneurons were used to study the pattern of expression, subcellular localization, and function of the neuronal cdk5 activator p35 during laminin-enhanced axonal growth. The results obtained indicate that laminin, an extracellular matrix molecule capable of selectively stimulating axonal extension and promoting MAP1B phosphorylation at a proline-directed protein kinase epitope, selectively stimulates p35 expression, increases its association with the subcortical cytoskeleton, and accelerates its redistribution to the axonal growth cones. Besides, suppression of p35, but not of a highly related isoform designated as p39, by antisense oligonucleotide treatment selectively reduces cdk5 activity, laminin-enhanced axonal elongation, and MAP1b phosphorylation. Taken collectively, the present results suggest that cdk5/p35 may serve as an important regulatory linker between environmental signals (e.g., laminin) and constituents of the intracellular machinery (e.g., MAP1B) involved in axonal elongation.
引用
收藏
页码:9858 / 9869
页数:12
相关论文
共 32 条
  • [21] Enhanced Cdk5 Activity and p35 Translocation in the Ventral Striatum of Acute and Chronic Methamphetamine-Treated Rats
    Pei-Chun Chen
    Jin-Chung Chen
    Neuropsychopharmacology, 2005, 30 : 538 - 549
  • [22] Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats
    Chen, PC
    Chen, JC
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) : 538 - 549
  • [23] TFP5, a Peptide Derived from p35, a Cdk5 Neuronal Activator, Rescues Cortical Neurons from Glucose Toxicity
    Binukumar, B. K.
    Zheng, Ya-Li
    Shukla, Varsha
    Amin, Niranjana D.
    Grant, Philip
    Pant, Harish C.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (04) : 899 - 909
  • [24] A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation
    Zheng, Ya-Li
    Amin, Niranjana D.
    Hu, Ya-Fang
    Rudrabhatla, Parvathi
    Shukla, Varsha
    Kanungo, Jyotshnabala
    Kesavapany, Sashi
    Grant, Philip
    Albers, Wayne
    Pant, Harish C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (44) : 34202 - 34212
  • [25] Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells
    Chen, Mei-Chih
    Lin, Ho
    Hsu, Fu-Ning
    Huang, Pao-Hsuan
    Lee, Guan-Shun
    Wang, Paulus S.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 299 (02): : C516 - C527
  • [26] Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases
    Binukumar, B. K.
    Pelech, Steven L.
    Sutter, Catherine
    Shukla, Varsha
    Amin, Niranjana D.
    Grant, Philip
    Bhaskar, Manju
    Skuntz, Suzanne
    Steiner, Joseph
    Pant, Harish C.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (02) : 525 - 533
  • [27] A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells
    Zheng, YL
    Li, BS
    Amin, ND
    Albers, W
    Pant, HC
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (18): : 4427 - 4434
  • [28] LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer's disease brains
    Morotz, Gabor M.
    Glennon, Elizabeth B.
    Gomez-Suaga, Patricia
    Lau, Dawn H. W.
    Robinson, Eleanor D.
    Sedlak, Eva
    Vagnoni, Alessio
    Noble, Wendy
    Miller, Christopher C. J.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (1) : 73
  • [29] Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2
    Smith, PD
    Mount, MP
    Shree, R
    Callaghan, S
    Slack, RS
    Anisman, H
    Vincent, I
    Wang, XM
    Mao, ZX
    Park, DS
    JOURNAL OF NEUROSCIENCE, 2006, 26 (02) : 440 - 447
  • [30] Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system
    Zheng, M
    Leung, CL
    Liem, RKH
    JOURNAL OF NEUROBIOLOGY, 1998, 35 (02): : 141 - 159